Market research
603087.SHG Gan & Lee Pharmaceuticals
SHG CNY Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 43B
- P/E ratio
- 37.11
- Analyst target
- 83.5
- Dividend yield
- 1.5%
- Beta
- 0.26
Profile
Instrument facts
- Exchange
- SHG
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- ISIN
- CNE100003ZH1
- Market cap
- 43B
- P/E ratio
- 37.11
- Analyst target
- 83.5
- Dividend yield
- 1.5%
- Beta
- 0.26
About
About Gan & Lee Pharmaceuticals
Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the development, production, and commercialization of insulin analogs and medical devices in China. Its products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro injection; Prandilin 25, an insulin lispro mix 75/25 injection; Rapilin, an insulin aspart injection; Rapilin 30, an insulin aspart 30 injection; and Similin 30, a mixed protamine human insulin injection. The company also offers GanleePen, an insulin injection device; and GanleeFine, an insulin pen needle. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceuticals. in April 2005. Gan & Lee Pharmaceuticals. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
Research context
Gan & Lee Pharmaceuticals appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
0 comments
Sign in to join the 603087.SHG discussion.
No comments yet
Start a focused discussion about 603087.SHG.